Camden County Man Admits Selling Phony Prescriptions
For Immediate Release
U.S. Attorney's Office, District of New Jersey
CAMDEN, N.J. – A former employee of a Mount Holly, New Jersey, medical practice pleaded guilty today to selling fraudulent prescriptions for controlled substances, U.S. Attorney Philip R. Sellinger announced.
Jose Colon, 37, of Sicklerville, New Jersey, pleaded guilty before U.S. District Judge Christine P. O’Hearn to an information charging him with distribution of controlled substances.
According to documents filed in this case and statements made in court:
Colon, who is not a medical provider, used the identities of doctors with whom he worked to make and sell fraudulent prescriptions for controlled substances, including Oxycodone, Adderall, Percocet, and Xanax. Colon sometimes met his customers in person with a prescription pad to sell the fraudulent prescriptions for cash. He also submitted fraudulent prescriptions electronically to pharmacies in exchange for electronic payments from his customers. Colon advised his customers on how to fill the fraudulent prescriptions, including instructing them to wait until the medical practice was closed so that Colon would be able to answer any phone calls from the pharmacies questioning the validity of the fraudulent prescriptions.
The count of distributing controlled substances carries a maximum potential penalty of 20 years in prison and a $1 million fine. Sentencing is scheduled for June 7, 2022.
U.S. Attorney Sellinger credited special agents of the FBI Newark Division, Atlantic City Resident Agency, under the direction of Special Agent in Charge George M. Crouch Jr. in Newark, with the investigation leading to today’s guilty plea. He also thanked the FBI Newark Health Care Fraud Task Force, whose members include the Galloway Township and Middle Township Police Departments, and the Cape May County Prosecutor’s Office, for their assistance.
The government is represented by Assistant U.S. Attorney Jeffrey Bender of the U.S. Attorney’s Office in Camden.
Updated February 2, 2022
Press Release Number: 22-035